Gilead, Merck team up to develop long-acting HIV drug
Criteria published for diagnosing the clinical syndrome of CTE during life
15 March 2021Vulnerable newborns being separated from their mothers in COVID-19 pandemic
15 March 2021Gilead, Merck team up to develop long-acting HIV drug
American pharmaceutical companies Gilead and Merck announced Monday they have partnered to develop a new HIV therapy that could see daily medications replaced by a treatment that can be taken at longer intervals.
